UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

Further Studies of Attention Deficit Disorder - Residual Type (RT)

Phase 3

Completed

Conditions: Attention Deficit Hyperactivity Disorder

Interventions: Drug: methylphenidate
Drug: placebo

First Posted Date: 2008-06-06

Last Posted Date: 2008-06-06

Lead Sponsor: University of Utah

Target Recruit Count: 116

Registration Number: NCT00693212

Locations: 🇺🇸
Univ of Utah, School of Medicine, Mood Disorders Clinic, SLC, Utah, United States

HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)

Recruiting

Conditions: Pediatric Hydrocephalus

First Posted Date: 2008-05-02

Last Posted Date: 2024-12-18

Lead Sponsor: University of Utah

Target Recruit Count: 1400

Registration Number: NCT00670735

Locations: 🇺🇸
Children's Hospital of Alabama, University of Alabama, Birmingham, Alabama, United States
🇺🇸
Children's Hospital of Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

and more 11 locations

Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Drug: Copper T380 IUD
Drug: levonorgestrel

First Posted Date: 2008-04-30

Last Posted Date: 2014-12-22

Lead Sponsor: University of Utah

Target Recruit Count: 57

Registration Number: NCT00669396

Locations: 🇺🇸
Planned Parenthood Association of Utah, West Valley City Clinic, West Valley City, Utah, United States

Effects of Xoçai Antioxidant Supplements on Atherosclerosis Risk Factors

Not Applicable

Completed

Conditions: Hyperglycemia
Hypertension
Dyslipidemia

Interventions: Dietary Supplement: Xocai Activ drink

First Posted Date: 2008-04-24

Last Posted Date: 2016-02-08

Lead Sponsor: University of Utah

Target Recruit Count: 10

Registration Number: NCT00666250

Locations: 🇺🇸
Cardiovascular Genetics, University of Utah, Salt Lake City, Utah, United States

Strength Training and Medication Effects in Parkinson Disease Effects on Hypokinesia in Parkinson Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Resistance Exercise via Negative Eccentric Work
Behavioral: Standard care exercise training

First Posted Date: 2008-04-23

Last Posted Date: 2011-09-21

Lead Sponsor: University of Utah

Target Recruit Count: 41

Registration Number: NCT00665184

Locations: 🇺🇸
University of Utah Health Sciences Center, Salt Lake City, Utah, United States

CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I

Phase 1

Completed

Conditions: Spinal Muscular Atrophy Type I

Interventions: Drug: Valproic Acid and Levocarnitine

First Posted Date: 2008-04-18

Last Posted Date: 2015-06-15

Lead Sponsor: University of Utah

Target Recruit Count: 40

Registration Number: NCT00661453

Locations: 🇺🇸
University of Wisconsin Children's Hospital, Madison, Wisconsin, United States
🇺🇸
Children's Hospital of Michigan, Detroit, Michigan, United States
🇩🇪
Klinikum der Universität zu Köln, Cologne, Germany

and more 5 locations

Comparison of Humidified High Flow Nasal Cannula to Nasal CPAP in Neonates

Not Applicable

Completed

Conditions: Respiratory Insufficiency

Interventions: Other: Nasal CPAP
Other: Humidified High Flow Nasal Cannula (HHFNC)

First Posted Date: 2008-02-07

Last Posted Date: 2013-02-06

Lead Sponsor: University of Utah

Target Recruit Count: 420

Registration Number: NCT00609882

Locations: 🇺🇸
Wilford Hall Medical Center, Lackland AFB, Texas, United States
🇺🇸
Utah Valley Regional Medical Center, Provo, Utah, United States
🇺🇸
University Hospital, Salt Lake City, Utah, United States

and more 6 locations

A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Erlotinib (Tarceva)

First Posted Date: 2008-01-03

Last Posted Date: 2013-07-30

Lead Sponsor: University of Utah

Target Recruit Count: 40

Registration Number: NCT00585533

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Myocardial Hemodynamic Effects of Levosimendan

Phase 2

Completed

Conditions: Heart Failure

Interventions: Drug: levosimendan

First Posted Date: 2008-01-03

Last Posted Date: 2013-05-21

Lead Sponsor: University of Utah

Target Recruit Count: 10

Registration Number: NCT00585104

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Drug: phenylephrine

First Posted Date: 2008-01-03

Last Posted Date: 2012-06-13

Lead Sponsor: University of Utah

Target Recruit Count: 15

Registration Number: NCT00585091

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy